Evidence map›Paper›PMID 37323353›Full record

ArticleCureus2023

Atraumatic Splenic Rupture: A Notable Complication of Rivaroxaban Use.

Catherine A Ostos Perez, Kristina Menchaca, Can X Jones, Erika Ostos Perez, Shaun Isaac

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Catherine A Ostos PerezInternal Medicine, University of Miami John F. Kennedy Medical Center, Atlantis, USA.
Kristina MenchacaInternal Medicine, University of Miami John F. Kennedy Medical Center, Atlantis, USA.
Can X JonesInternal Medicine, University of Miami John F. Kennedy Medical Center, Atlantis, USA.
Erika Ostos PerezBiological Sciences, St. Petersburg College, Clearwater, USA.
Shaun IsaacInternal Medicine, University of Miami John F. Kennedy Medical Center, Atlantis, USA.
John F. Kennedy Medical Center · USClearwater Christian College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct oral anticoagulants (DOACs) are well known to be associated with bleeding complications. However, little is known about their association with atraumatic splenic rupture, a potentially fatal condition. We present the case of a 73-year-old female with paroxysmal atrial fibrillation managed with rivaroxaban who developed a spontaneous atraumatic splenic rupture. This highlights the importance of recognizing this complication in patients without previous risk factors, such as abdominal trauma or infiltrative splenic disease, who are under anticoagulation with DOACs. There is a strong need for further research on this complication's underlying mechanism and management.

Indexed as

atraumatic splenic ruptureatrial fibdirect oral anticoagulants (doac)major bleeding eventsmedication side-effectsnewer oral anticoagulantsnon-vitamin k oral anticoagulantsecondary stroke preventionspontaneous splenic rupturetherapeutic anticoagulation

Identifiers

PMID37323353
PMCPMC10262104
OpenAlexW4376565501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.